Inflammatory Breast Cancer
1 competing product in clinical development for Inflammatory Breast Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Eribulin + Adriamycin + Cyclophosphamide | Eisai | Phase 2 | Active | 39 |
1 competing product in clinical development for Inflammatory Breast Cancer.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Eribulin + Adriamycin + Cyclophosphamide | Eisai | Phase 2 | Active | 39 |